You are here: Home » News-IANS » Science-Tech
Business Standard

Researchers find pause button for mouse embryos

IANS  |  New York 

A novel way to pause the development of early mouse embryos for up to a month in the lab has been identified, a finding that has potential implications for assisted reproduction, regenerative medicine, ageing and even cancer, researchers say.

In the study, the researchers were able to stop the development of early-stage mouse embryos -- known as blastocysts -- using drugs that inhibit the activity of mTor, a master regulator of cell growth.

"Normally, blastocysts only last a day or two, maximum, in the lab. But blastocysts treated with mTOR inhibitors could survive up to four weeks," said the study's lead author Aydan Bulut-Karslioglu, post-doctoral student at the University of California -San Francisco (UCSF).

The paused embryos could quickly resume normal growth when mTOR inhibiters were removed. When implanted back into a recipient mother, they developed into healthy mice, the researchers said.

"mTOR is this beautiful regulator of developmental timing that works by being a nutrient sensor. It doesn't just drive cells into growing willy-nilly. It tunes cell growth based on the level of nutrients that are available in the environment," added Miguel Ramalho-Santos, Associate Professor at UCSF.

The new research could have a big impact on the field of assisted reproduction -- technology used to achieve pregnancy in procedures such as fertility medication, artificial insemination, in vitro fertilisation and surrogacy -- where practitioners are currently limited by the rapid degradation of embryos once they reach the blastocyst stage.

Further, pausing the development of early-stage embryos may also avoid the compromise of freezing embryos and give practitioners more time to test fertilised blastocysts for genetic defects before implanting them, Bulut-Karslioglu said.

Humans too may have the ability to delay implantation of fertilised embryos in some circumstances, suggested the practitioners of in vitro fertilisation, in the paper published online in the journal Nature.

--IANS

rt/py/vt

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

RECOMMENDED FOR YOU

Researchers find pause button for mouse embryos

A novel way to pause the development of early mouse embryos for up to a month in the lab has been identified, a finding that has potential implications for assisted reproduction, regenerative medicine, ageing and even cancer, researchers say.

A novel way to pause the development of early mouse embryos for up to a month in the lab has been identified, a finding that has potential implications for assisted reproduction, regenerative medicine, ageing and even cancer, researchers say.

In the study, the researchers were able to stop the development of early-stage mouse embryos -- known as blastocysts -- using drugs that inhibit the activity of mTor, a master regulator of cell growth.

"Normally, blastocysts only last a day or two, maximum, in the lab. But blastocysts treated with mTOR inhibitors could survive up to four weeks," said the study's lead author Aydan Bulut-Karslioglu, post-doctoral student at the University of California -San Francisco (UCSF).

The paused embryos could quickly resume normal growth when mTOR inhibiters were removed. When implanted back into a recipient mother, they developed into healthy mice, the researchers said.

"mTOR is this beautiful regulator of developmental timing that works by being a nutrient sensor. It doesn't just drive cells into growing willy-nilly. It tunes cell growth based on the level of nutrients that are available in the environment," added Miguel Ramalho-Santos, Associate Professor at UCSF.

The new research could have a big impact on the field of assisted reproduction -- technology used to achieve pregnancy in procedures such as fertility medication, artificial insemination, in vitro fertilisation and surrogacy -- where practitioners are currently limited by the rapid degradation of embryos once they reach the blastocyst stage.

Further, pausing the development of early-stage embryos may also avoid the compromise of freezing embryos and give practitioners more time to test fertilised blastocysts for genetic defects before implanting them, Bulut-Karslioglu said.

Humans too may have the ability to delay implantation of fertilised embryos in some circumstances, suggested the practitioners of in vitro fertilisation, in the paper published online in the journal Nature.

--IANS

rt/py/vt

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Researchers find pause button for mouse embryos

A novel way to pause the development of early mouse embryos for up to a month in the lab has been identified, a finding that has potential implications for assisted reproduction, regenerative medicine, ageing and even cancer, researchers say.

In the study, the researchers were able to stop the development of early-stage mouse embryos -- known as blastocysts -- using drugs that inhibit the activity of mTor, a master regulator of cell growth.

"Normally, blastocysts only last a day or two, maximum, in the lab. But blastocysts treated with mTOR inhibitors could survive up to four weeks," said the study's lead author Aydan Bulut-Karslioglu, post-doctoral student at the University of California -San Francisco (UCSF).

The paused embryos could quickly resume normal growth when mTOR inhibiters were removed. When implanted back into a recipient mother, they developed into healthy mice, the researchers said.

"mTOR is this beautiful regulator of developmental timing that works by being a nutrient sensor. It doesn't just drive cells into growing willy-nilly. It tunes cell growth based on the level of nutrients that are available in the environment," added Miguel Ramalho-Santos, Associate Professor at UCSF.

The new research could have a big impact on the field of assisted reproduction -- technology used to achieve pregnancy in procedures such as fertility medication, artificial insemination, in vitro fertilisation and surrogacy -- where practitioners are currently limited by the rapid degradation of embryos once they reach the blastocyst stage.

Further, pausing the development of early-stage embryos may also avoid the compromise of freezing embryos and give practitioners more time to test fertilised blastocysts for genetic defects before implanting them, Bulut-Karslioglu said.

Humans too may have the ability to delay implantation of fertilised embryos in some circumstances, suggested the practitioners of in vitro fertilisation, in the paper published online in the journal Nature.

--IANS

rt/py/vt

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

image
Business Standard
177 22

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard